Discover

MANE
Veradermics, Incorporated
111.59
1 x 111.00
1 x 111.83
bid
ask
+
2.10
1.92%
12:01 PM
timesize
Ytd195.60%
1y195.60%
108.19
day range
112.29
32.00
52 week range
131.24
Open108.45Prev Close109.49Low108.19High112.29Mkt Cap4.57B
Vol74.47KAvg Vol706.40KEPS-3.14P/E-34.86Forward P/E-39.37
BetaN/AShort Ratio5.22Inst. Own80.12%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1350-d Avg106.69200-d Avg81.841yr Est161.00
Income Statement
Operating Expenses29.86M
Research and Development Expense20.93M
Selling, General and Administrative Expense8.94M
Operating Income-29.86M
Net Income-30.01M
Net Income Common Stock-30.01M
Net Income Common Stock (USD)-30.01M
Consolidated Income-27.23M
Net Income to Non-Controlling Interests2.78M
Earnings per Basic Share-1.32
Earnings per Basic Share (USD)-1.32
Earnings per Diluted Share-1.32
Earning Before Interest & Taxes (EBIT)-30.01M
Earning Before Interest & Taxes (USD)-30.01M
Weighted Average Shares22.70M
Weighted Average Shares Diluted22.70M
Balance Sheet
Cash and Equivalents168.41M
Cash and Equivalents (USD)168.41M
Investments222.39M
Investments Current222.39M
Current Assets397.07M
Property, Plant & Equipment Net287.00K
Total Assets397.36M
Current Liabilities6.72M
Total Liabilities6.72M
Accumulated Retained Earnings (Deficit)-150.65M
Accumulated Other Comprehensive Income-524.00K
Shareholders Equity390.64M
Shareholders Equity (USD)390.64M
Assets Non-Current287.00K
Trade and Non-Trade Payables1.07M
Cash Flow
Net Cash Flow from Financing269.11M
Net Cash Flow / Change in Cash & Cash Equivalents146.65M
Issuance (Purchase) of Equity Shares269.11M
Net Cash Flow from Investing-101.30M
Net Cash Flow - Investment Acquisitions and Disposals-101.30M
Net Cash Flow from Operations-21.17M
Share Based Compensation5.26M